Objectives To our knowledge no previous study has assessed the performance of a rapid
antigen diagnostic immunoassay (RAD) conducted at the point of care (POC). We evaluated …

Whether antibody levels measured by commercially available enzyme or chemiluminescent
immunoassays targeting the SARS-CoV-2 spike (S) protein can act as a proxy for serum …

Abstract Knowledge of the precise timing of SARS‐CoV‐2 infection may be of clinical and
epidemiological relevance. The presence of low‐avidity IgGs has conventionally been …

Assessment of commercial severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
immunoassays for their capacity to provide reliable information on sera neutralizing activity …

We optimized and prospectively evaluated a simple MALDI-TOF MS-based method for direct
detection of third-generation oxymino-cephalosporin resistance (3rd CephR) in Escherichia …

To the Editor, Serological testing is increasingly recognized as a useful tool for management
of the coronavirus disease‐2019(COVID‐19) pandemic. 1 Cross‐sectional serosurveys …

We evaluated the Panbio™ COVID-19 AG Rapid Test Device (RAD) for the diagnosis of
COVID-19 in symptomatic patients attended in primary healthcare centers (n=412). Overall …

To the Editor, Real‐time reverse transcription polymerase chain reaction (RT‐PCR) is the
mainstay of coronavirus disease 2019 (Covid‐19) diagnosis. 1 Up to 30% of the patients …

We were very interested to read the article by Pan and colleagues, 1 and related letter by
Cancella de Abreu 2 supporting the diagnostic utility of SARS-CoV-2 Lateral Flow …

The performance of a laboratory-developed quantitative IgG/IgA flow cytometry-based
immunoassay (FCI) using Jurkat T cells stably expressing full-length native S protein was …